1.
Vopr Onkol
; 22(6): 16-23, 1976.
Article
in Russian
| MEDLINE
| ID: mdl-969339
ABSTRACT
As a result of distance gamma-therapy on Rocus-123 machine in patients with pulmonary cancer in stage II-IV, the survival for a year period and longer was noted in 57.5 +/- 4.5%, over 3 years--in 19.5 +/- 3.6%; over 5 years--in 7.2+/- 2.4%. An average life survival was 21.6 +/- 1.8%.